The Trump administration will end a subsidy program, meant to keep premiums stable for Medicare prescription drug plans, after 2026, the Centers for Medicare & Medicaid Services said on Tuesday. The agency said its review of 2027 bids showed insurers have gained enough experience with Medicare Part D to accurately price their plans without support from the program. "We are stabilizing the market so this bailout is no longer needed. Premiums will go up by less than $10 for most Medicare recipients, with many even seeing lower premiums," CMS Administrator Dr. Mehmet Oz said in a post on X.